Kemper’s AbbVie ABBV Stock Holding History

Kemper’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-30,300	Closed	-$1.77M	–	18
2015 Q1	$1.77M	Hold	30,300	–	–	0.55%	28
2014 Q4	$1.98M	Sell	30,300 -29,700	-50%	-$1.87M	0.61%	24
2014 Q3	$3.47M	Hold	60,000	–	–	1.09%	25
2014 Q2	$3.39M	Hold	60,000	–	–	1.05%	27
2014 Q1	$3.08M	Hold	60,000	–	–	0.93%	30
2013 Q4	$3.17M	Hold	60,000	–	–	1.04%	27
2013 Q3	$2.68M	Hold	60,000	–	–	0.89%	29
2013 Q2	$2.48M	Buy	+60,000	New	+$2.62M	0.83%	25

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Kemper's ABBV Position: Q2 2015 in Review

Kemper sold out of AbbVie (ABBV) in Q2 2015, closing a stake of 30,300 shares — an estimated $1.77M sold.

Kemper first reported a position in ABBV in Q2 2013 and held it in 8 quarters. The position peaked at $3.47M in Q3 2014. 1,654 funds tracked by Wall St. Rank hold ABBV as of Q2 2015.

Kemper reported no remaining AbbVie position as of Q2 2015 after selling out during the quarter.
Kemper sold 30,300 AbbVie shares in Q2 2015, an estimated $1.77M.
Kemper first reported a position in AbbVie in Q2 2013 and held it in 8 quarters.
Kemper's AbbVie position peaked at $3.47M in Q3 2014.
1,654 funds tracked by Wall St. Rank held AbbVie as of Q2 2015.

Based on Kemper's 13F filing for Q2 2015, filed 7 Aug 2015.